Tag

Ba286 Subvariant

All articles tagged with #ba286 subvariant

health2 years ago

Moderna's Updated COVID Vaccine Proven Effective Against New Variant

Moderna announced that its updated COVID-19 vaccine is likely to be effective against the highly-mutated BA.2.86 subvariant of the coronavirus. Clinical trial data showed that the vaccine generated an 8.7-fold increase in neutralizing antibodies against BA.2.86. This variant has raised concerns due to its potential to cause infections in individuals previously infected or vaccinated. Moderna has shared the findings with regulators and submitted them for peer review publication. The retooled vaccine is expected to be available later this month or in early October.

health2 years ago

"Assessing the Risk: CDC Cautions on Covid Subvariant's Impact"

The Centers for Disease Control and Prevention (CDC) stated that it is too early to determine the potential disruption caused by the new BA.2.86 subvariant of the SARS-CoV-2 virus. The CDC also announced that updated Covid-19 vaccines from Pfizer, Moderna, and Novavax could be available in mid-September, earlier than expected. However, the vaccines still need authorization from the FDA and recommendations from the CDC's expert vaccine panel. The BA.2.86 subvariant contains numerous mutations, similar to the Omicron variant, but its impact and severity are still unknown. The CDC believes the updated vaccines will be effective against the subvariant, but further scientific data is needed. The rise in Covid cases is not attributed to BA.2.86, and global surveillance and sequencing efforts have declined, hindering the assessment of the subvariant's spread. Existing Covid tests can detect the subvariant, and certain antiviral drugs are expected to be effective. Scientists caution against premature conclusions and emphasize the need for continued monitoring.

health2 years ago

BA.2.86 Variant: A Growing Concern for Breakthrough Infections

The BA.2.86 COVID-19 subvariant, recently detected in several countries, including the U.S., may have a higher ability to cause breakthrough infections in individuals who have previously had the virus or been vaccinated, according to a risk assessment by the CDC. It is unclear if this strain causes more severe illness. The BA.2.86 subvariant has more mutations compared to other strains descended from the Omicron subvariant, raising concerns about its potential to evade existing immunity from vaccines and previous infections. However, the real-world impact of this variant on immunity is still unknown. The World Health Organization has designated BA.2.86 as a "variant under monitoring."